Method for preparing intestinal virus vaccine by using gerbil kidney cell
An enterovirus and kidney cell technology, applied in animal cells, antiviral agents, vertebrate cells, etc., can solve the problems of low reproductive titer, low efficiency, yield limitation, etc., and achieve the effect of convenient purification and simple production process.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0020] Embodiment 1: Preparation of EV71 monovalent vaccine
[0021] (1) Preparation of cell monolayer
[0022] Take gerbils aged 10-15 days, cut off the carotid artery and bleed to death, soak in 0.2% (v / v) new clean and disinfectant solution for 30 minutes, take the kidney aseptically, cut it into pieces, and contain 100U / ml kanamycin Wash three times with MEM culture solution, centrifuge to remove the washing solution; add 0.25% (w / v) trypsin digestion solution 10 times the weight of the kidney, and digest at 4°C; discard the digestion solution after 16 hours, and wash once with MEM culture solution . Add MEM solution 10 times the weight of the kidney to disperse the cells by pipetting repeatedly, add newborn bovine serum to a final concentration of 3% (v / v), inoculate the cell bottle, and culture at 36°C for 2-3 days. When the cell growth reached 50%-60% confluence, the MEM culture with 3% (v / v) newborn bovine serum was replaced to continue the culture. When the cells r...
Embodiment 2
[0034] Embodiment 2: Preparation of CoxA16 vaccine
[0035] In Example 1, the inoculated virus was replaced with the CoxA16 virus strain (provided by Hangzhou Sixth People's Hospital), and the other preparation methods were the same, and CoxA16 vaccine semi-finished products and finished vaccines could be prepared.
Embodiment 3
[0036] Embodiment 3: Preparation of EV71 and CoxA16 bivalent vaccine
[0037] The EV71 vaccine semi-finished product prepared in Example 1 and the CoxA16 vaccine semi-finished product prepared in Experimental Example 2 were mixed at a volume ratio of 1:1 and subpackaged to obtain a bivalent enterovirus vaccine.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com